Suppr超能文献

ADAM33 基因多态性与中国东北地区 COPD 的相关性研究。

Association of ADAM33 gene polymorphisms with COPD in a northeastern Chinese population.

机构信息

Department of Respiratory, the Second Affiliated Hospital of Harbin Medical University, Harbin 150081, PR China.

出版信息

BMC Med Genet. 2009 Dec 10;10:132. doi: 10.1186/1471-2350-10-132.

Abstract

BACKGROUND

Chronic obstructive pulmonary disease (COPD) is influenced by both environmental and genetic factors. ADAM33 (a disintegrin and metalloproteinase 33) has been one of the most exciting candidate genes for asthma since its first association with the disease in Caucasian populations. Recently, ADAM33 was shown to be associated with excessive decline of lung function and COPD. The aim of this study was to evaluate the potential relationship between polymorphisms of ADAM33 and COPD in a Han population in northeastern China.

METHODS

A total of 312 COPD patients and a control group of 319 healthy volunteers were recruited for this study. Eight polymorphic loci (V4, T+1, T2, T1, S2, S1, Q-1, and F+1) of ADAM33 were selected for genotyping. Genotypes were determined by using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method.

RESULTS

Statistically significant differences in the distributions of the T2G, T1G, S2C, and Q-1G alleles between patients and controls were observed (P < 0.001, odds ratio (OR) = 2.81, 95% confidence interval (CI) = 2.19-3.61; P < 0.001, OR = 2.60, 95% CI = 2.06-3.30; P = 0.03, OR = 1.31, 95% CI = 1.02-1.69; and P < 0.001, OR = 1.93, 95% CI = 1.50-2.50, respectively). Haplotype analysis showed that the frequencies of the CGGGGAGC, CGGGGAGT, CGGGCAGC, and CGGGGGGC haplotypes were significantly higher in the case group than in the control group (P = 0.0002, 0.0001, 0.0005, and 0.0074, respectively). In contrast, the haplotype CGAAGAGC was more common in the control group than in the case group (P < 0.0001).

CONCLUSION

These preliminary results suggest an association between ADAM33 polymorphisms and COPD in a Chinese Han population.

摘要

背景

慢性阻塞性肺疾病(COPD)受环境和遗传因素的影响。自从 ADAM33(解整合素和金属蛋白酶 33)首次与白种人群的哮喘相关联以来,它一直是最令人兴奋的候选基因之一。最近,ADAM33 被证明与肺功能过度下降和 COPD 有关。本研究旨在评估 ADAM33 多态性与中国东北地区汉族人群 COPD 之间的潜在关系。

方法

本研究共纳入 312 例 COPD 患者和 319 例健康对照者。选择 ADAM33 的 8 个多态性位点(V4、T+1、T2、T1、S2、S1、Q-1 和 F+1)进行基因分型。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法确定基因型。

结果

患者组与对照组在 T2G、T1G、S2C 和 Q-1G 等位基因的分布上存在统计学差异(P<0.001,优势比(OR)=2.81,95%置信区间(CI)=2.19-3.61;P<0.001,OR=2.60,95%CI=2.06-3.30;P=0.03,OR=1.31,95%CI=1.02-1.69;P<0.001,OR=1.93,95%CI=1.50-2.50)。单体型分析显示,病例组中 CGGGGAGC、CGGGGAGT、CGGGGCAGC 和 CGGGGGGC 单体型的频率明显高于对照组(P=0.0002、0.0001、0.0005 和 0.0074)。相反,CGAAGAGC 单体型在对照组中的频率高于病例组(P<0.0001)。

结论

这些初步结果提示 ADAM33 多态性与中国汉族人群 COPD 之间存在关联。

相似文献

1
Association of ADAM33 gene polymorphisms with COPD in a northeastern Chinese population.
BMC Med Genet. 2009 Dec 10;10:132. doi: 10.1186/1471-2350-10-132.
2
Association of ADAM33 gene polymorphisms with COPD in the Mongolian population of China.
Ann Hum Biol. 2014 Jan-Feb;41(1):9-14. doi: 10.3109/03014460.2013.821165. Epub 2013 Nov 5.
3
Association of ADAM33 gene with susceptibility to COPD in Tibetan population of China.
Mol Biol Rep. 2011 Nov;38(8):4941-5. doi: 10.1007/s11033-010-0637-6. Epub 2010 Dec 15.
4
Association of ADAM33 gene polymorphisms with keloid scars in a northeastern Chinese population.
Cell Physiol Biochem. 2014;34(3):981-7. doi: 10.1159/000366314. Epub 2014 Aug 27.
6
Association of ADAM33 gene polymorphisms with psoriasis in a northeastern Chinese population.
Mol Biol Rep. 2014 Jun;41(6):4001-5. doi: 10.1007/s11033-014-3268-5. Epub 2014 Feb 22.
9
The ADAM33 S2 polymorphism is associated with susceptibility to pediatric asthma in the Chinese Han population.
Genet Test Mol Biomarkers. 2015 Oct;19(10):573-8. doi: 10.1089/gtmb.2014.0332. Epub 2015 Aug 20.
10
Association of ADAM33 gene polymorphisms with asthma in a Chinese population.
Clin Respir J. 2013 Jan;7(1):16-20. doi: 10.1111/j.1752-699X.2011.00261.x. Epub 2011 Jul 18.

引用本文的文献

2
A network-based approach to uncover microRNA-mediated disease comorbidities and potential pathobiological implications.
NPJ Syst Biol Appl. 2019 Nov 13;5:41. doi: 10.1038/s41540-019-0115-2. eCollection 2019.
3
genetic polymorphisms influence chronic obstructive pulmonary disease susceptibility in the Hainan population.
Int J Chron Obstruct Pulmon Dis. 2019 Sep 5;14:2103-2115. doi: 10.2147/COPD.S214961. eCollection 2019.
4
Locked Nucleic Acid Gapmers and Conjugates Potently Silence ADAM33, an Asthma-Associated Metalloprotease with Nuclear-Localized mRNA.
Mol Ther Nucleic Acids. 2017 Sep 15;8:158-168. doi: 10.1016/j.omtn.2017.06.012. Epub 2017 Jun 21.
5
Genetic polymorphism and chronic obstructive pulmonary disease.
Int J Chron Obstruct Pulmon Dis. 2017 May 10;12:1385-1393. doi: 10.2147/COPD.S134161. eCollection 2017.
6
genetic variations associated with COPD risk in the Chinese Han population.
Int J Chron Obstruct Pulmon Dis. 2016 Oct 14;11:2563-2571. doi: 10.2147/COPD.S109026. eCollection 2016.
7
A predictive model for the development of chronic obstructive pulmonary disease.
Biomed Rep. 2015 Nov;3(6):853-863. doi: 10.3892/br.2015.503. Epub 2015 Aug 5.
9
Associations of ABHD2 genetic variations with risks for chronic obstructive pulmonary disease in a Chinese Han population.
PLoS One. 2015 Apr 16;10(4):e0123929. doi: 10.1371/journal.pone.0123929. eCollection 2015.
10
Genetic variants in ADAM33 are associated with airway inflammation and lung function in COPD.
BMC Pulm Med. 2014 Nov 4;14:173. doi: 10.1186/1471-2466-14-173.

本文引用的文献

2
New concepts in the pathobiology of chronic obstructive pulmonary disease.
Proc Am Thorac Soc. 2008 May 1;5(4):478-85. doi: 10.1513/pats.200802-014ET.
3
The soluble form of a disintegrin and metalloprotease 33 promotes angiogenesis: implications for airway remodeling in asthma.
J Allergy Clin Immunol. 2008 Jun;121(6):1400-6, 1406.e1-4. doi: 10.1016/j.jaci.2008.03.003. Epub 2008 Apr 14.
4
A disintegrin and metalloprotease 33 and chronic obstructive pulmonary disease pathophysiology.
Thorax. 2007 Mar;62(3):242-7. doi: 10.1136/thx.2006.060988. Epub 2006 Nov 7.
6
A disintegrin and metalloproteinase 33 protein in patients with asthma: Relevance to airflow limitation.
Am J Respir Crit Care Med. 2006 Apr 1;173(7):729-35. doi: 10.1164/rccm.200409-1175OC. Epub 2005 Dec 30.
7
Genetics of chronic obstructive pulmonary disease.
Semin Respir Crit Care Med. 2003 Apr;24(2):151-60. doi: 10.1055/s-2003-39014.
8
ADAM33: a newly identified protease involved in airway remodelling.
Pulm Pharmacol Ther. 2006;19(1):3-11. doi: 10.1016/j.pupt.2005.02.008. Epub 2005 Jun 13.
9
A disintegrin and metalloprotease 33 polymorphisms and lung function decline in the general population.
Am J Respir Crit Care Med. 2005 Aug 1;172(3):329-33. doi: 10.1164/rccm.200411-1486OC. Epub 2005 May 5.
10
Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function.
Am J Respir Crit Care Med. 2005 Jul 1;172(1):55-60. doi: 10.1164/rccm.200412-1708OC. Epub 2005 Apr 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验